Baseline Relative Peripheral Refraction in Myopia Control
NCT ID: NCT06161311
Last Updated: 2024-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
80 participants
INTERVENTIONAL
2023-12-01
2025-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the current study, we will investigate the influence of baseline RPR in myopia retardation using DIMS lenses among young myopic children.
This will ba a 1-year prospective clinical trial. Through G\*Power (version 3.1.9.6) calculation, 80 healthy myopic subjects (40 myopic RPR vs 40 hyperopic RPR) aged 5-9 years should be needed. After screened by inclusion criteria, eligible participants will be assigned to wear DIMS lenses for 1 year (12 months, 8 hour per day, 7 days per week). This study includes 5 visits: Visit 1: baseline, Visit 2: lens dispensing, Visit 3: 2-week follow-up, Visit 4: 6-month follow-up, and Visit 5: 12-month follow-up. All eye examinations will be carried out in the Optometry Research Centre (A137), the School of Optometry, the Hong Kong Polytechnic University. The main data collection, including refractive error, axial length, related ocular parameters will be measured at baseline, 6-month and 1-year visits. At the lens dispensing and 2-week follow-up visits, vision acuity testing and computer scanning of posterior eyes will be measured. New DIMS lens will be replaced and upgraded if the equivalent sphere of refraction (SER) is changed or visual acuity change.
The following data will be statistically analyzed. The primary outcome data include the difference in change in SER with cycloplegia between the myopic and hyperopic RPR from the baseline over 12 months of treatment. Secondary outcomes data include the changes in axial length, peripheral refraction, relative peripheral refraction, the amplitude of accommodation, lag of accommodation, corneal curvature, phoria and stereoacuity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
NCT05062031
Myopia Control With the Multi-segment Lens
NCT02206217
Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes - Auxiliary Group
NCT05888805
Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes
NCT05888792
Defocus-Enhanced vs. Single Vision Spectacles in Myopia Control Visual Function Training
NCT06821074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myopic RPR group
Patients with myopic relative peripheral refraction
DIMS lenses
Defocus incorporated multiple segments lenses, which use induce peripheral myopic defocus to control for myopia development in children
Hyperopic RPR group
Patients with hyperopic relative peripheral refraction
DIMS lenses
Defocus incorporated multiple segments lenses, which use induce peripheral myopic defocus to control for myopia development in children
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DIMS lenses
Defocus incorporated multiple segments lenses, which use induce peripheral myopic defocus to control for myopia development in children
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spherical equivalent refraction (SER): -0.75 to -5.00 Diopters (D)
* Astigmatism: -1.50 D or less
* Anisometropia: 1.50 D or less
* Spectacle best-corrected monocular visual acuity (VA): 0.00 logMAR or better
Exclusion Criteria
* Prior use of any drugs or optical devices of myopia control treatment.
6 Years
9 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Eye and Vision Research
OTHER
HOYA Lamphun Ltd
INDUSTRY
The Hong Kong Polytechnic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LEUNG Tsz Wing
Research Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Optometry Research Clinic
Hong Kong, Hong Kong, Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSEARS20221229003-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.